论文部分内容阅读
目的:观察沙美特罗丙酸氟替卡松吸入治疗稳定期慢性阻塞性肺疾病的疗效。方法:选取本院2012年3月—2013年3月收治的50例慢性阻塞性肺疾病患者作为研究对象,按照药物治疗的不同,将患者平均分为观察组以及对照组,每组25例,对照组采取常规的药物治疗,观察组在其基础上采取沙美特罗丙酸氟替卡松吸入治疗,用药结束后,对两组患者的临床疗效进行比较。结果:治疗后,观察组患者肺泡氧分压(Pa O2)以及动脉血二氧化碳分压(Pa CO2)均明显优于对照组,组间比较,差异具有统计学意义(P<0.05)。观察组肺功能指标、治疗效果显著高于对照组,组间比较,差异具有统计学意义(P<0.05)。结论:沙美特罗丙酸氟替卡松吸入治疗稳定期慢性阻塞性肺疾病的疗效显著,可使肺功能得到有效的改善,降低患者的发作次数,提高患者的生活质量以及疗效。
Objective: To observe the efficacy of salmeterol fluticasone propionate inhalation in patients with stable chronic obstructive pulmonary disease. Methods: Fifty patients with chronic obstructive pulmonary disease who were treated in our hospital from March 2012 to March 2013 were selected as study subjects. According to the different drug treatment, the patients were equally divided into observation group and control group, with 25 cases in each group. The control group to take conventional medication, the observation group on the basis of salmeterol fluticasone propionate inhalation therapy, after the end of the medication, the clinical efficacy of the two groups were compared. Results: After treatment, the PaO2 and PaCO2 in the observation group were significantly better than those in the control group. The differences between the two groups were statistically significant (P <0.05). Observation group, pulmonary function indicators, the treatment effect was significantly higher than the control group, compared between groups, the difference was statistically significant (P <0.05). Conclusion: Salmeterol fluticasone propionate inhalation in the treatment of stable chronic obstructive pulmonary disease has obvious curative effect, which can effectively improve pulmonary function, reduce the number of patients’ seizures and improve the quality of life of patients and the curative effect.